Evidence map›Paper›PMID 33799847›Full record

ArticleMembranes2021

Impact of CRRT in Patients with PARDS Treated with VV-ECMO.

Sébastien Redant, Océane Barbance, Ashita Tolwani, Xavier Beretta-Piccoli, Jacques Massaut, David De Bels, Fabio S Taccone, Patrick M Honoré, Dominique Biarent

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Membranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Sébastien RedantDepartments of Intensive Care, Brugmann University Hospital, 1020 Brussels, Belgium.
Océane BarbanceDepartments of Intensive Care, Brugmann University Hospital, 1020 Brussels, Belgium.
Ashita TolwaniDivision of Nephrology, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35233, USA.
Xavier Beretta-PiccoliDepartments of Intensive Care, Hospital Universitaire des Enfants Reine Fabiola (HUDERF), 1020 Brussels, Belgium.
Jacques MassautDepartments of Intensive Care, Brugmann University Hospital, 1020 Brussels, Belgium.
David De BelsDepartments of Intensive Care, Brugmann University Hospital, 1020 Brussels, Belgium.
Fabio S TacconeDepartment of Intensive Care, Hopital Erasme, Université Libre de Bruxelles, 1020 Brussels, Belgium.
Patrick M HonoréDepartments of Intensive Care, Brugmann University Hospital, 1020 Brussels, Belgium.
Dominique BiarentDepartments of Intensive Care, Hospital Universitaire des Enfants Reine Fabiola (HUDERF), 1020 Brussels, Belgium.
Centre Hospitalier Universitaire Brugmann · BEQueen Fabiola Children's University Hospital · BEUniversité Libre de Bruxelles · BEUniversity of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high mortality of pediatric acute respiratory distress syndrome (PARDS) is partly related to fluid overload. Extracorporeal membrane oxygenation (ECMO) is used to treat pediatric patients with severe PARDS, but can result in acute kidney injury (AKI) and worsening fluid overload. The objective of this study was to determine whether the addition of CRRT to ECMO in patients with PARDS is associated with increased mortality.

methodsWe conducted a retrospective 7-year study of patients with PARDS requiring ECMO and divided them into those requiring CRRT and those not requiring CRRT. We calculated severity of illness scores, the amount of blood products administered to both groups, and determined the impact of CRRT on mortality and morbidity.

resultsWe found no significant difference in severity of illness scores except the vasoactive inotropic score (VIS, 45 ± 71 vs. 139 ± 251,

conclusionThe addition of CRRT to ECMO is associated with a greater consumption of blood products but no increase in mortality.

Indexed as

AKIARDSCRRTECMOpediatric

Identifiers

PMID33799847
PMCPMC7999958
OpenAlexW3134902729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.